Drug · DIN 02240409
REPLAVITE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 31, 2002; first marketed October 20, 1999.
- Drug Identification Number (DIN)
- 02240409
- Company (DIN owner)
- Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Vitamin b-complex with vitamin c A11EB
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VITAMIN B1 (THIAMINE MONONITRATE) | 1.5 MG | TAB |
| VITAMIN B2 (VITAMIN B2) | 1.7 MG | TAB |
| NICOTINAMIDE | 20 MG | TAB |
| FOLIC ACID | 1 MG | TAB |
| VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) | 10 MG | TAB |
| D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) | 10 MG | TAB |
| VITAMIN B12 (VITAMIN B12) | 6 MCG | TAB |
| BIOTIN | 300 MCG | TAB |
| ASCORBIC ACID (ASCORBIC ACID) | 100 MG | TAB |
Other DINs named REPLAVITE
- DIN 02244872 · Cancelled Post Market